Efforts to develop the MYC G4-targeting DNAi 5T will continue in NHL but are more broadly applicable to other MYC-reliant cancers, such as breast [55,56,57], lung [58], colon [59], and many more cancers [60]. Here, MYC is linked to non-Hodgkin lymphoma.